Eric Tardif
Founder presso Maravai Life Sciences, Inc.
Profilo
Eric Tardif ha fondato Maravai Lifesciences Holdings, Inc. e Maravai Life Sciences, Inc. Il signor Tardif occupa la posizione di presidente di Vector Laboratories, Inc., presidente e socio di Maravai Life Sciences, Inc. e presidente di Maravai Lifesciences Holdings, Inc. Eric Tardif è stato in precedenza vicepresidente senior della strategia aziendale di Hologic, Inc. e vicepresidente senior dello sviluppo aziendale e del marketing di Gen-Probe, Inc. (una filiale di Hologic, Inc.). Ha conseguito una laurea presso la Bishop's University, un MBA presso la University of British Columbia e una laurea presso il Boston College.
Posizioni attive di Eric Tardif
Società | Posizione | Inizio |
---|---|---|
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Founder | 18/03/2014 |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | President | - |
Precedenti posizioni note di Eric Tardif
Società | Posizione | Fine |
---|---|---|
MARAVAI LIFESCIENCES HOLDINGS, INC. | Founder | 30/06/2021 |
HOLOGIC, INC. | Corporate Officer/Principal | - |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 18/10/2011 |
Formazione di Eric Tardif
Boston College | Graduate Degree |
University of British Columbia | Masters Business Admin |
Bishop's University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
HOLOGIC, INC. | Health Technology |
MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | Process Industries |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |
- Borsa valori
- Insiders
- Eric Tardif